Ginés Luengo Gil-rekin lankidetzan egindako argitalpenak (2)

2023

  1. A new prognostic model including immune biomarkers, genomic proliferation tumor markers (AURKA and MYBL2) and clinical-pathological features optimizes prognosis in neoadjuvant breast cancer patients

    Frontiers in Oncology, Vol. 13

2022

  1. Prognostic and Predictive Effects of Tumor and Plasma miR-200c-3p in Locally Advanced and Metastatic Breast Cancer

    Cancers, Vol. 14, Núm. 10